Rakesh Popat, MBBS, MRCP, FRCPath, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, highlights real world, multi-centre data collected in patients with relapsed/refractory multiple myeloma treated with daratumumab monotherapy and their response to subsequent treatments. These data were submitted as an abstract to the BSH 2020 meeting. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).